Ilan Bruchim - Publications

An Enigmatic Case of Rectal Bleeding in a Young Woman-A Forgotten Intrauterine Device, Perforation and Rectal Involvement: A Case Report and Literature Review.

Journal: Journal of clinical medicine

Published: June 27, 2026

Adverse event profile following maintenance olaparib in patients with BRCA-mutated platinum-sensitive relapsed serous ovarian cancer in the phase III SOLO2 trial.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Published: October 16, 2025

Revisiting the paradigm: Asymptomatic high-grade endometrial cancer diagnosis is not associated with improved outcomes.

Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology

Published: June 16, 2025

SALVOVAR: a pragmatic randomized phase III trial comparing the SALVage weekly dose-dense regimen to the standard 3-weekly regimen in patients with poor prognostic OVARian cancers.

Journal: Therapeutic advances in medical oncology

Published: June 06, 2025

Use of individualized starting dose and niraparib hematologic adverse event management costs in ovarian cancer.

Journal: Journal of comparative effectiveness research

Published: December 06, 2024

Atezolizumab Combined With Platinum and Maintenance Niraparib for Recurrent Ovarian Cancer With a Platinum-Free Interval >6 Months: ENGOT-OV41/GEICO 69-O/ANITA Phase III Trial.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: September 18, 2024

Niraparib first-line maintenance therapy in patients with newly diagnosed advanced ovarian cancer: final overall survival results from the PRIMA/ENGOT-OV26/GOG-3012 trial.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: July 29, 2024

IGF1R inhibition and PD-1 blockade improve anti-tumor immune response in epithelial ovarian cancer.

Journal: Frontiers in oncology

Published: May 02, 2024

New therapeutic targets for endometrial cancer: a glimpse into the preclinical sphere.

Journal: Expert opinion on therapeutic targets

Published: February 08, 2024

The MISOPRED score: Development and validation of a clinical scoring system to predict the effectiveness of Misoprostol treatment for early pregnancy loss.

Journal: PloS one

Published: October 25, 2023

Assessment of oncological safety and utility of hysteroscopy in high grade endometrial cancers: Results from an Israel gynecologic oncology group study.

Journal: European journal of obstetrics, gynecology, and reproductive biology

Published: September 25, 2023

Prediction of endometrial cancer recurrence by using a novel machine learning algorithm: An Israeli gynecologic oncology group study.

Journal: Journal of gynecology obstetrics and human reproduction

Published: February 15, 2022